ClinicalTrials.gg
Enrolling by invitationNCT06649084Updated Oct 8, 2025

Primary Progressive Aphasia Multicomponent Language Treatment Study

An interventional study of Multicomponent Lexical Retrieval Training (Multi-LRT) and Multicomponent Video Implemented Script Training in Aphasia (Multi-VISTA) in Primary Progressive Aphasia, Semantic Dementia and Semantic Memory Disorder, sponsored by University of Texas at Austin. Enrolling by invitation at 1 site in United States. Per ClinicalTrials.gov, last updated 2025-10-08.

Primary conditionPrimary Progressive Nonfluent AphasiaRegistry: Aphasia, Primary ProgressiveReclassifiedWhy we changed it
Registry
Aphasia, Primary Progressive — the first condition term the registry derived for this study.
ClinicalTrials.gg
Primary Progressive Nonfluent Aphasia
Why
  1. The study's listed conditions name Primary Progressive Nonfluent Aphasia, a narrower term within Aphasia, Primary Progressive.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by University of Texas at Austin · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Dec 2025, 10 months ago, but the record still lists the study as enrolling by invitation.
  • Registered 1 year 5 months after the study started (first participant enrolled May 2023, registered Oct 2024).
Phase
Not applicable
Study type
Interventional
Enrollment
21
Allocation
Non-randomized
Sex
All
01

Study summary

The goal of this clinical trial is to learn if a speech-language telerehabilitation helps improve communication in people with primary progressive aphasia (PPA), a form of dementia that affects speech and language. The study will also document how acceptable and helpful the program is for both patients and their care partners.

The main questions the study aims to answer are:

  1. Is the telerehabilitation program feasible and acceptable for people with PPA and their care partners?
  2. Do participants with PPA and care partners report satisfaction with the program?
  3. Which outcome measures are most useful for evaluating changes in communication and quality of life?
  4. What patterns of treatment response are seen in participants after completing the program?

Researchers will test the program in a small group of participants to see how people respond. The program includes both speech-language therapy and training for care partners.

Participants will:

  • Take part in online speech-language therapy sessions
  • Complete communication tasks and questionnaires before and after the program
  • Have regular virtual check-ins with the research team
  • Include their care partners in some parts of the program for training and support
02

Conditions studied

  • Primary Progressive Aphasia
  • Semantic Dementia
  • Semantic Memory Disorder
  • Logopenic Progressive Aphasia
  • Nonfluent Aphasia, Progressive
  • Aphasia
  • Aphasia, Progressive

Keywords

  • Speech-Language Pathology
  • Neurodegenerative Disease
  • Logopenic
  • Semantic
  • Nonfluent
  • Speech Entrainment
  • Telethearpy
  • Multimodal Communication Training
  • Partner Training
  • Augmentative and Alternative Communication
  • Script training
03

In context

Primary Progressive Nonfluent Aphasia Reclassified

20 studies on the registry are indexed under Primary Progressive Nonfluent Aphasia; 8 are open to participants now.

This study's planned enrollment of 21 is below the median of 33 across 15 interventional studies indexed under Primary Progressive Nonfluent Aphasia.

Browse Primary Progressive Nonfluent Aphasia studies →

Lead sponsor

University of Texas at Austin is the lead sponsor of 328 studies on the registry; 79 are open to participants now.

Of its 10 completed or terminated interventional studies of FDA-regulated products, 5 (50%) have results posted.

Compared within Primary Progressive Nonfluent Aphasia, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Aphasia, Primary Progressive. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Meets diagnostic criteria for Primary Progressive Aphasia (PPA; Gorno-Tempini et al., 2011)
  • Scores of 10 or higher on the
  • Has a study partner who can consistently attend sessions

Exclusion criteria

Exclusion Criteria:

  • Other neurological or psychiatric diagnosis that may contribute to cognitive-linguistic deficits
  • Significant, uncorrected visual or hearing impairment that would interfere with participation
  • Score of less than 10 on the
  • Prominent initial non-speech-language impairment (cognitive, behavioral, motoric)
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
21 participants (estimated)

Study arms

  • Experimental
    Multicomponent Lexical Retrieval Training (Multi-LRT)

    Behavioral: Multicomponent Lexical Retrieval Training (Multi-LRT)

  • Experimental
    Multicomponent Video Implemented Script Training in Aphasia (Multi-VISTA)

    Behavioral: Multicomponent Video Implemented Script Training in Aphasia (Multi-VISTA)

  • Experimental
    Experimental: Multicomponent Communicaiton Partner Training (Multi-CPT)

    Behavioral: Multicomponent Communication Partner Training (Multi-CPT)

Interventions

  • BehavioralMulticomponent Lexical Retrieval Training (Multi-LRT)

    In person or via teletherapy: A multi-component treatment incorporating elements of restitutive, compensatory, and care-partner focused interventions. Participants work on producing names of personally relevant target in multiple communication modalities. Treatment focuses on the use of strategies which capitalize on residual linguistic ability and autobiographical memory to support word retrieval. The participant completes two one-hour-long sessions per week plus daily homework. The participant also meets 4 times during the course of treatment with a study partner (e.g., spouse) for communication counseling, education, and practice of communication strategies.

  • BehavioralMulticomponent Video Implemented Script Training in Aphasia (Multi-VISTA)

    In person or via teletherapy: A multi-component treatment incorporating elements of restitutive, compensatory, and care-partner focused interventions. Participants work on producing personally relevant scripts of 3-5 sentences in length. Length and complexity of scripts are individually tailored. The participant completes 30 minutes per day of home practice, during which they speak in unison with a video/audio model of a healthy speaker clearly articulating the scripts. Biweekly (one hour each) sessions with a clinician are held which target clear and accurate script production, script memorization, and conversational usage of the script and multimodal communication. The participant also meets 6 times during the course of treatment with a study partner (e.g., spouse) for communication counseling, education, and practice of communication strategies.

  • BehavioralMulticomponent Communication Partner Training (Multi-CPT)

    In person or via teletherapy: A multi-component treatment incorporating elements of compensatory and care-partner focused interventions. Biweekly (one hour each) sessions with a clinician are held which target use of communication strategies including multimodal communication for the participant and study partner (e.g., spouse). The participant also completes regular assignments meant to increase generalization of communication strategies and progress on personal goals.

06

What researchers measure

Primary outcomes

  1. Change in script production accuracy

    Percent correct intelligible, scripted words for trained/untrained scripts

    Time frame: change from pre-treatment to post-treatment (approximately 6-12 weeks after treatment onset) and follow-ups at 3 months post-treatment

  2. Change in spoken naming of trained/untrained items

    Percent correctly named trained/untrained pictures

    Time frame: change from pre-treatment to post-treatment (approximately 6-12 weeks after treatment onset) and follow-ups at 3 months post-treatment

  3. Information communicated in any modality for trained/untrained stimuli

    Percent of major content units (key words) communicated via speech or nonspeech modalities (e.g., writing, drawing, gesture) for trained/untrained scripts (Multi-VISTA) or words (Multi-LRT) during structured probes and in conversation

    Time frame: change from pre-treatment to post-treatment (approximately 6-12 weeks after treatment onset) and follow-ups at 3 months post-treatment

  4. Goal Attainment Score

    The Goal Attainment Score is self-reported progress on personalized goals based on a five point scale.

    Time frame: change from pre-treatment to post-treatment (approximately 6-12 weeks after treatment onset) and follow-ups at 3 months post-treatment

Secondary outcomes

  1. Change on Quick Aphasia Battery

    change on standardized aphasia assessment

    Time frame: change from pre-treatment to post-treatment (approximately 6-12 weeks after treatment onset) and follow-ups at 3 months post-treatment

  2. Change on Aphasia Impact Questionnaire

    change on psychosocial questionnaire for individuals with aphasia

    Time frame: change from pre-treatment to post-treatment (approximately 6-12 weeks after treatment onset) and follow-ups at 3 months post-treatment

Other outcomes

  1. Post-treatment Communication Survey

    survey characterizing perceived response to treatment

    Time frame: post-treatment (approximately 6-12 weeks after treatment onset)

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 8, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06649084
Responsible party
Maya Henry (Associate Professor, University of Texas at Austin) — Principal investigator
First posted
Oct 18, 2024
Start date
May 2, 2023
Primary completion
Dec 31, 2025 (estimated)
Completion
Dec 31, 2025 (estimated)
Last update
Oct 8, 2025

Study contacts

Maya L Henry, PhD
principal investigator · University of Texas at Austin

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion